Results 291 to 297 of about 359,848 (297)
Some of the next articles are maybe not open access.

Plasma proteomic profiles predict future dementia in healthy adults

Nature Aging
Yu Guo   +10 more
semanticscholar   +1 more source

The efficacy and toxicity of VAD in the treatment of myeloma and related disorders.

Scandinavian Journal of Haematology, 2009
T. Sheehan, M. Judge, A. Parker
semanticscholar   +1 more source

Vascular dementia

Neurology, 1993
G. Roman   +30 more
semanticscholar   +1 more source

VAD‐based regimens as primary treatment for multiple myeloma

American journal of hematology/oncology, 1990
R. Alexanian, B. Barlogie, S. Tucker
semanticscholar   +1 more source

Bortezomib/dexamethasone versus VAD as induction prior to autologous stem cell transplantion (ASCT) in previously untreated multiple myeloma (MM): Updated data from IFM 2005/01 trial

, 2008
J. Harousseau   +9 more
semanticscholar   +1 more source

First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HDM) in Patients with Newly Diagnosed Multiple Myeloma (MM)

, 2008
P. Sonneveld   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy